Brand Name
Tryngolza
Generic Name
Olezarsen
View Brand Information FDA approval date: December 19, 2024
Form: Injection
What is Tryngolza (Olezarsen)?
TRYNGOLZA is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome . TRYNGOLZA is an APOC-III -directed antisense oligonucleotide indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome .
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment